Patent ID: 8940726
Filing Date: 2015-01-27
Classification: A61K,A61P,C07D

Abstract:
1. A compound of Formula (I): or a pharmaceutically acceptable salt thereof, wherein: R X is —O— or —N(R)—; each R is hydrogen; R each R each R R Cy is a monocyclic or bicyclic, saturated, partially unsaturated, or aromatic ring system having 1-4 heteroatoms independently selected from nitrogen, oxygen, and sulfur, wherein Cy is substituted with 0, 1, 2, 3, or 4 R each R each R R′ is hydrogen, or optionally substituted aliphatic; each R″ is independently hydrogen or optionally substituted aliphatic, or two R″ are taken together with their intervening atoms to form an optionally substituted heterocyclic ring having 1-2 heteroatoms independently selected from nitrogen, oxygen, and sulfur; and n is 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10, as valency permits; wherein each instance of aliphatic is independently an alkyl, alkenyl, alkynyl, cycloalkyl, or cycloalkenyl group.